StockData
LB Pharmaceuticals Inc logo

LB Pharmaceuticals Inc (LBRX) stock

LBRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$40.06−0.24 (-0.60%)

Close on Nov 18, 2026Market cap $1.29BP/E –Yield –

LB Pharmaceuticals operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

No operating income figures for LB Pharmaceuticals

LB Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More LB Pharmaceuticals figures

See a number that looks wrong?